Andrew M. Evens, DO, MSc

How Best to Approach Hodgkin Lymphoma in Older Patients

Andrew M. Evens , DO, MSc;

10/26/2019

What is the best upfront approach for the treatment of advanced stage Hodgkin lymphoma?

Andrew M. Evens , DO, MSc;

10/20/2018

Videos

Current Treatment Landscape for Patients With Relapsed/Refractory Hodgkin Lymphoma

08/24/2023

Andrew M. Evens , DO, MSc;

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Evens, DO, MBA, MSc, discusses current treatment options for patients with Hodgkin lymphoma after relapse occurs.

At the 2023 Great Debates &...

08/24/2023

Oncology

Videos

Antibody Drug Conjugates for the Frontline Treatment of Patients With Advanced-Stage Hodgkin Lymphoma

09/05/2023

Andrew M. Evens , DO, MSc;

Andrew Evens, DO, MBA, MSc, analyzes the first-line treatment landscape for patients with advanced-stage Hodgkin lymphoma through the integration of antibody drug conjugates, at the 2023 Great Debates & Updates in Hematologic Malignancies...

Andrew Evens, DO, MBA, MSc,...

09/05/2023

Oncology

Videos

Predicting Long-Term Effects Among Patients Treated for Early-Stage Hodgkin Lymphoma

09/07/2023

Andrew M. Evens , DO, MSc;

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Evens, DO, MBA, MSc, discusses the management and prediction of long-term effects among patients treated for early-stage Hodgkin lymphoma.

At the 2023 Great Debates &...

09/07/2023

Oncology